Celecoxib as Heterotopic Ossification Prophylaxis in Total Ankle Arthroplasty: A Retrospective Cohort Study.

Foot Ankle Orthop · 2025 · PMC12123132 · PMID 40453511

Europe PMC DOI

hedged sentence

0.3100

closest p · 6.2× alpha

0.3100

boldest claim

The sentences

did not reach statistical significanceP = .31not close (p > 0.1)

The number of reoperations for symptomatic HO was less in the celecoxib group (n = 2) than in the control group (n = 3), but this did not reach statistical significance ( P = .31).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.